Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 386

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 386
---
) | each registered holder of such Common Shares shall cease to be the registered holder thereof and to have any 
 rights as a Shareholder other than the right to be paid one CVR per Common Share;                            |

| (ii) | the name of each such registered holder shall be removed from the register of the Shareholders maintained by or 
 on behalf of the Company; and                                                                                   |

| (iii) | the Purchaser shall be deemed to be the transferee of such Common Shares free and clear of all Encumbrances and 
 shall be entered in the register of the Shareholders maintained by or on behalf of the Company; and             |

E-6

| (h) | the exchanges and cancellations provided for in this Section 2.3 will be deemed to occur on the Effective              
 Date, notwithstanding that certain of the procedures related thereto are not completed until after the Effective Date. |

ARTICLE 3 RIGHTS OF DISSENT

| 3.1 | Rights of Dissent |

Each registered holder of Common Shares as of the Record Date may exercise dissent rights with respect to all Common Shares held by such holder (“ Dissent Rights”) in connection with the Arrangement pursuant to and in the manner set forth in Chapter XIV – Division I of the QBCA, as modified by this Section 3.1, the Interim Order and any other order of the Court, provided that, as a condition precedent to the exercise of Dissent Rights and notwithstanding Section 376 of the QBCA, the written notice setting forth such a registered Shareholder’s objection to the Arrangement Resolution and exercise of Dissent Rights must be received by the Company not later than 5:00 p.m. (Montréal time) two Business Days immediately preceding the date of the Meeting (as it may be adjourned or postponed from time to time). Each Dissenting Shareholder that duly exercises such holder’s Dissent Rights shall, notwithstanding anything to the contrary in Section 376 of the QBCA, be deemed to have transferred the Common Shares held by such holder and in respect of which Dissent Rights have been validly exercised to the Purchaser free and clear of all Encumbrances (other than the right to be paid Fair Value for such Common Shares as set out in this Section 3.1), as provided in Section 2.3(f) and if they:

| (a) | ultimately are entitled to be paid Fair Value for such Common Shares: (i) shall be deemed to have